Fertility Monitoring Technologies Market (2026-2036)
The global fertility monitoring technologies market was valued at USD 2.1 billion in 2025. This market is expected to reach USD 5.8 billion by 2036 from an estimated USD 2.4 billion in 2026, growing at a CAGR of 9.2% during the forecast period 2026-2036.
- Published
- May 2026
- Pages
- 310
- Format
- PDF + Excel
- Report ID
- MRHC - 1041975
- Base year
- 2025
- 2025 · BASELINE
- $2.10B
- 2036
- $5.80B
- CAGR 2026–2036
- 9.2%
2025 baseline · 2026–2036 forecast at 9.2% CAGR · hover a bar for the value
Key highlights
The global fertility monitoring technologies market is projected to reach USD 5.8 billion by 2036.
The market is expected to grow at a CAGR of 9.2% during the forecast period 2026-2036.
The global market for fertility monitoring technologies was valued at USD 2.1 billion in 2025 and is estimated to reach USD 2.4 billion in 2026.
North America is expected to dominate the global fertility monitoring technologies market with the largest market share in 2026, while Asia-Pacific is projected to register the highest CAGR during the forecast period.
By product type, the ovulation prediction kits segment is expected to hold the largest share of the market in 2026, while the wearable fertility tracking devices segment is projected to register the highest CAGR during the forecast period.
By technology, the hormone-based detection segment is expected to hold the largest share in 2026, while the AI-based predictive analytics segment is projected to register the highest CAGR during the forecast period.
By usage mode, the home-based monitoring segment is expected to hold the largest share in 2026, while the hybrid models segment is projected to register the highest CAGR during the forecast period.
By application, the ovulation tracking and fertility planning segment is expected to hold the largest share in 2026, while the infertility diagnosis and treatment support segment is projected to register the highest CAGR during the forecast period.
By end user, the individuals and consumers segment is expected to hold the largest share in 2026, while the fertility clinics segment is projected to register the highest CAGR during the forecast period.
Report summary
| Particulars | Details |
|---|---|
| Market Size by 2036 | USD 5.8 Billion |
| Market Size in 2026 | USD 2.4 Billion |
| Market Size in 2025 | USD 2.1 Billion |
| Revenue Growth Rate (2026-2036) | CAGR of 9.2% |
| Format | PDF, Excel & Cloud Portal · 310 pages |
| Dominating Product Type | Ovulation Prediction Kits (OPKs) |
| Fastest Growing Product Type | Wearable Fertility Tracking Devices |
| Dominating Technology | Hormone-based Detection (LH, Estrogen) |
| Fastest Growing Technology | AI-based Predictive Analytics |
| Dominating Usage Mode | Home-based Monitoring |
| Fastest Growing Usage Mode | Hybrid Models |
| Dominating Application | Ovulation Tracking & Fertility Planning |
| Fastest Growing Application | Infertility Diagnosis & Treatment Support |
| Dominating End User | Individuals / Consumers |
| Fastest Growing End User | Fertility Clinics |
| Dominating Geography | North America |
| Fastest Growing Geography | Asia-Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2036 |
Report overview
Segments covered: product type, technology, usage mode, application, end user.
According to the World Health Organization’s 2023 infertility report, about 1 in 6 adults globally, roughly 17.5%, experience infertility at some point in their lives, supporting strong and growing demand for fertility care and monitoring tools ranging from ovulation kits to hormone-tracking wearables and AI-based fertility apps.
Fertility monitoring technologies are devices, software platforms, and diagnostic tools that help individuals and couples understand, track, and optimize their reproductive health by measuring the physiological signals that indicate fertility status throughout the menstrual cycle. At the simplest level, an ovulation prediction kit detects the surge in luteinizing hormone in urine that precedes ovulation by 24 to 36 hours, providing a reliable short-term fertility window signal. At the most sophisticated end, continuous wearable devices monitor basal body temperature, heart rate variability, skin conductance, and breathing patterns throughout the night to build personalized fertility window predictions calibrated to each user's unique hormonal cycle patterns, with AI algorithms that improve prediction accuracy over multiple cycles of data collection.
The market is growing because the structural drivers are broad, well-established, and intensifying. According to the WHO's infertility report, approximately 1 in 6 people are affected by infertility globally, representing approximately 17.5% of the adult population. The global trend toward delayed childbearing, with the average age of first childbirth rising in most developed countries, is both increasing the proportion of couples experiencing fertility challenges due to age-related decline and extending the period during which fertility awareness is commercially relevant. According to the Centers for Disease Control and Prevention's 2025 National Survey of Family Growth, approximately 12% of U.S. women aged 15 to 44 have used fertility monitoring or ovulation testing services, establishing a large and growing domestic market.
The femtech industry's rapid growth is a particularly important commercial context. Natural Cycles, the first FDA-cleared digital contraceptive app using algorithm-based fertility prediction, reported over 4 million users globally according to its 2025 annual report, demonstrating the scale of consumer appetite for evidence-based digital fertility solutions. Ava Science's FDA-cleared wearable fertility tracker has been peer-reviewed and validated in multiple clinical studies, establishing the clinical credibility of multi-sensor wearable fertility monitoring. The convergence of validated clinical evidence and consumer-friendly design across multiple product categories is progressively elevating the entire fertility monitoring market from a commodity-driven OPK market toward a higher-value, tech-enabled personalized health category.
Report infographic
Market dynamics
7 factors across 3 forcesRising Infertility Rates Globally
According to the World Health Organization's report on infertility, approximately 1 in 6 people globally experience infertility, representing approximately 17.5% of the adult population. In the United States, the CDC's 2025 National Survey of Family Growth estimated approximately 12% of women aged 15 to 44 have experienced difficulty getting pregnant or carrying a pregnancy to term. The CDC also reported the average age of first birth in the United States at 27.5 years in 2024, up from 21.4 years in 1970, with the growing proportion of conceptions attempted after age 35 creating a larger population with both higher clinical need for fertility monitoring and higher awareness of fertility tracking tools.
Growth of Femtech and Digital Health Platforms
PitchBook’s 2025 femtech investment snapshot indicates that femtech attracted about $1.2 billion in 2024, with fertility monitoring and reproductive health among the leading investment areas. Consumer platforms such as Natural Cycles and Flo Health also show the scale of engagement in this segment, with large registered-user bases supporting broad distribution for fertility monitoring technologies.
Table of contents
13 chapters · 149 sections · 310 pages · click to expandSegmental analysis
| Segment | Largest share (2026) | Fastest growth (2026–2036) |
|---|---|---|
| By Product Type | Ovulation Prediction Kits (OPKs) | Wearable fertility tracking devices |
| By Technology | Hormone-based Detection | AI-based predictive analytics |
| By Usage Mode | Home-based Monitoring | Hybrid models |
| By Application | Ovulation Tracking & Fertility Planning | Infertility diagnosis and treatment support |
| By End User | Individuals / Consumers | Fertility clinics |
By Product Type
- Ovulation Prediction Kits (OPKs) to Hold the Largest Share
- The ovulation prediction kits segment is expected to account for the largest share of the global fertility monitoring technologies market.
- OPKs are the most universally used fertility monitoring product, with broad retail availability, very low per-test cost, and decades of established clinical evidence.
- Clearblue's digital ovulation tests, which detect both LH and estrogen to provide a wider fertility window indication than LH-only tests, represent the dominant premium OPK brand globally.
- The accessibility and affordability of OPKs make them the entry point for the majority of women beginning fertility tracking, sustaining their dominant market share.
- However, the wearable fertility tracking devices segment is projected to register the highest CAGR during the forecast period.
- Continuous wearable monitoring that provides passive, user-friendly fertility tracking without daily test administration is the fastest-growing premium product category, driven by the clinical validation of Ava Science's FDA-cleared tracker, growing consumer comfort with health wearables, and the appeal of multi-parameter physiological monitoring.
- The rapidly declining cost of wearable sensor hardware is progressively making premium wearable fertility trackers accessible at price points that a growing proportion of consumers can afford.
By Technology
- Hormone-based Detection to Hold the Largest Share
- The hormone-based detection segment is expected to account for the largest share of the global fertility monitoring technologies market.
- Hormonal biomarkers, particularly LH which surges 24 to 36 hours before ovulation, provide the most clinically validated fertility signals available outside a clinical laboratory.
- Clearblue's digital hormone monitors, which simultaneously detect urinary LH and estrogen metabolite levels to provide a fertility window of up to six days per cycle, represent the most commercially successful hormone-based detection product globally.
- However, the AI-based predictive analytics segment is projected to register the highest CAGR during the forecast period.
- AI fertility prediction platforms that integrate data from multiple monitoring modalities to generate personalized fertility predictions represent the fastest-growing technology category.
- Natural Cycles' FDA-cleared algorithm and Flo Health's AI prediction models are the leading commercial implementations, with combined disclosed user bases in the tens of millions that provide large-scale training data for continuous accuracy improvement.
By Usage Mode
- Home-based Monitoring to Hold the Largest Share
- The home-based monitoring segment is expected to account by far the largest share of the global fertility monitoring technologies market.
- The entire consumer fertility monitoring market operates primarily in the home setting, and the fundamental value proposition of fertility monitoring technology is enabling users to access fertility health information privately and conveniently without requiring clinical appointments.
- Natural Cycles' over 4 million users and Flo Health's over 70 million users reflect the enormous consumer scale of this home-based segment.
- However, the hybrid models segment is projected to register the highest CAGR during the forecast period.
- Hybrid approaches that combine home-based monitoring with clinical interpretation, telehealth consultations, and integration with fertility clinic electronic health records are growing as fertility monitoring technologies develop clinical-grade capabilities relevant to healthcare providers.
- Platforms that allow a woman to share her fertility monitoring data with her reproductive endocrinologist during a telehealth consultation bridge the consumer and clinical domains in ways that are creating a new and fast-growing hybrid commercial segment.
By Application
- Ovulation Tracking & Fertility Planning to Hold the Largest Share
- The ovulation tracking and fertility planning segment is expected to account for the largest share of the global fertility monitoring technologies market.
- Couples actively trying to conceive represent the most motivated and highest-spending user group, with willingness to purchase multiple monitoring modalities, premium devices, and subscription analytics services to maximize their probability of conception.
- This is the application for which the market was originally designed and where the commercial evidence base is most extensive.
- However, the infertility diagnosis and treatment support segment is projected to register the highest CAGR during the forecast period.
- The very large and growing population seeking clinical fertility treatment, combined with the growing integration of home monitoring data into clinical fertility workflows, is creating a fast-growing segment that commands premium pricing.
- Quantitative hormone monitoring devices like Mira that provide data directly relevant to clinical fertility assessment, and wearables validated for use in IVF monitoring protocols, are gaining traction in this higher-value clinical support application category.
By End User
- Individuals / Consumers to Hold the Largest Share
- The individuals and consumers segment is expected to account for the largest share of the global fertility monitoring technologies market.
- The direct-to-consumer fertility monitoring market, encompassing OPK retail sales, fertility app subscriptions, wearable device sales, and at-home hormone testing kits, is far larger in aggregate revenue than institutional procurement.
- Natural Cycles' over 4 million users and Flo Health's over 70 million users represent the enormous consumer scale that generates recurring subscription revenues and device sales far exceeding clinical institutional procurement.
- However, the fertility clinics segment is projected to register the highest CAGR during the forecast period.
- Fertility clinics are increasingly integrating digital monitoring tools into their clinical protocols, using quantitative hormone monitoring devices for remote cycle monitoring during IVF stimulation, prescribing FDA-cleared fertility tracking apps as part of natural cycle monitoring protocols, and adopting wearable sensors for continuous patient monitoring between clinic visits.
- The growing clinical validation of home fertility monitoring devices and the efficiency gains for fertility clinics from using validated home monitoring data to reduce the frequency of clinic-based monitoring appointments are driving above-average growth in this segment.
Geographic analysis
North America
Largest shareIn 2026, North America is expected to account for the largest share of the global fertility monitoring technologies market. The United States is the world's most commercially advanced fertility monitoring market, with the highest consumer awareness and adoption, the most active regulatory framework including FDA clearances for Natural Cycles and Ava Science, and a very large population of reproductive-age women actively managing fertility. According to the CDC's 2025 National Survey of Family Growth, approximately 12% of U.S. women aged 15 to 44 have used fertility monitoring services, representing tens of millions of women. The CDC also reported the average age of first birth in the U.S. at 27.5 years in 2024, reflecting the delayed childbearing trend that expands demand. The high consumer willingness to pay premium prices for validated fertility monitoring devices makes the U.S. the highest per-user revenue market globally.
Asia-Pacific
Fastest growthHowever, the Asia-Pacific fertility monitoring technologies market is expected to grow at the fastest CAGR during the forecast period. Asia-Pacific combines very large populations with growing consumer health awareness, rising disposable incomes, high smartphone penetration enabling mobile fertility app adoption, and structural demographic pressures including declining birth rates in Japan, South Korea, China, and Singapore that are making fertility monitoring a government and healthcare priority. Japan's government announced fertility treatment subsidies in 2025, creating government-supported demand for reproductive health services. South Korea faces among the world's lowest total fertility rates, with Statistics Korea 2025 data confirming the continued birth rate decline, creating strong societal demand for reproductive health support. China's government promotion of higher birth rates and its policy of supporting fertility planning services is creating government-level demand signals for fertility monitoring adoption. India's very large reproductive-age population and rapidly growing urban middle class with increasing health technology awareness are creating a large and growing OPK and fertility app market.
Europe
Europe is a technically advanced and regulation-active fertility monitoring market where Natural Cycles, founded in Sweden, maintains strong market penetration. The UK, Germany, France, and Sweden are the largest European fertility monitoring markets, with high consumer health technology adoption, well-developed pharmacy retail channels, and growing integration of digital fertility tools into gynecological clinical practice. According to Pitchbook's 2025 data, the European femtech ecosystem supported by active investor communities in London, Berlin, and Stockholm continues generating new fertility monitoring companies and products.
Latin America
Latin America and the Middle East and Africa are emerging markets where rising smartphone penetration and growing e-commerce access are creating early-stage but growing demand.
Competitive landscape
- Clearblue/SPD Swiss Precision Diagnostics GmbH · Switzerland
- Ava Science Inc. (U.S./Switzerland)
- Natural Cycles Nordic AB (Sweden/U.S.)
- OvuSense/Fertility
Frequently asked questions
The global fertility monitoring technologies market is expected to reach USD 5.8 billion by 2036 from an estimated USD 2.4 billion in 2026, at a CAGR of 9.2% during the forecast period 2026-2036.
Cite this report
Meticulous Research. (2026). Fertility Monitoring Technologies Market - Global Opportunity Analysis and Industry Forecast (2026-2036) (Report No. MRHC - 1041975). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/fertility-monitoring-technologies-market-6658